FDA Approved: NYMALIZE — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves NYMALIZE (nimodipine) from Azurity Pharmaceuticals in an original NDA (NDA203340). The product is indicated for use in subarachnoid hemorrhage to i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• NYMALIZE (Nimodipine)

Snippet

ORIG AP for NYMALIZE (NIMODIPINE)